CXCL12 and neoplasm: Cytokines and chemokines such as these factors CXCL1, CXCL12, IL-1β, and vascular endothelial growth factor (VEGF) enhance the tumor- and inflammation-promoting effects of p53 inactivation in CAFs [4].